From: Cancer cachexia: molecular mechanisms and treatment strategies
Pathway | Signaling | Regulator | Signaling implicated | Function | Expression | References |
---|---|---|---|---|---|---|
Anabolic | mTOR | mTORC1 | S6 kinase phosphorylation | Regulates protein synthesis | Decreased | |
 |  |  | FGF21 induction and mitochondrial biogenesis | Regulates muscle growth and positively associated with muscle mass |  |  |
 |  | mTORC2 | Phosphorylates PKB/Akt on Ser473 | Regulates glucose and lipid homeostasis |  | |
 | Insulin and IGF1-AKT | IGF1 | mTOR activator | Regulates protein synthesis and degradation, cellular proliferation, glucose uptake, and energy production |  | |
 |  |  | P13K/AKT activation |  | [150] | |
 |  |  | Suppression of MuRF1 and Atrogin-1 |  | [150] | |
 |  | AKT | Inhibits the NF-kB pathway and the FoxO protein | Regulates muscle growth |  | [137] |
 |  | Plakoglobin | Activation of PI3K-AKT-FoxO signaling | Controls muscle growth and metabolism |  | [151] |
 | BMP/Smad1/5/8 | BMP | Smad1/5/8 phosphorylation | Positive regulator of muscle mass growth |  | |
 |  | BMP7 | Activation of Smad1/5/8 signaling | Regulates protein synthesis |  | [157] |
Catabolic | Ubiquitin–proteasome system | Myostatin | Represses the Akt/mTOR pathway; activates SMAD2 and SMAD3 transcription; upregulates MuRF1, MAFbx/Atrogin1, and FOXO expression | Positive regulator of protein breakdown | Increased | |
 |  | Activin A |  | |||
 |  |  | Induces BMP inhibitor Noggin expression | BMP activity inhibitor in muscle fibers and motor nerves |  | [156] |
 |  | Smad2/3 | Regulates myostatin and activin A expression | Negative regulators of muscle growth |  | |
 | NF-κB | NF-κB | IGF1 inhibitor | Regulator of muscle cell death and specific transcriptional regulation |  | |
 |  |  | Suppresses MyoD expression |  |  | |
 |  |  | Increases MuRF1 expression | Positive regulators of proteolysis of skeletal muscle proteins |  | [306] |
 |  |  | iNOS/NO pathway regulator | Negative regulator of skeletal muscle growth |  | |
 |  | NIK | increases the levels of atrophy markers |  | [306] | |
 | Inflammatory cytokines | TNF-α | NF-κB activation; involved in the ubiquitin conjugation and proteasomal degradation of iKb | Positive regulators of proteolysis of skeletal muscle proteins |  | |
 |  |  | induces the expression of ubiquitin genes in the UPS and activates the p38 MAPK pathway | Stimulates both reactive oxygen production and general activity of the ubiquitin-conjugating pathway |  | [164] |
 | IL-6-JAK-STAT3 | STAT3 | Stimulates mitochondrial respiration | Promotes myogenic lineage progression in muscle stem cells |  | |
 |  |  | Increase expression of myostatin, MAFbx, and MURF1 | Regulates skeletal muscle mass in myofibers |  | |
 |  |  | Activation of the IκB kinase (IKK)/NF-κB signaling pathway | Positive regulators of apoptosis |  | [307] |
 |  |  | Stimulates C/EBPδ expression and activity |  | ||
 |  | IL-6 | Induces STAT3 phosphorylation | Positive regulators skeletal muscle proteolysis |  | |
 |  |  | Activation of IL3 |  | [[206] | |
 |  |  | AMPK activation and suppression of mTORC1 activation |  | [133] | |
 |  |  | Induces BMP inhibitor Noggin expression | Negative regulator of BMP activity in muscle fibers and motor nerves |  | [156] |
 | Cell autophagy/lysosomal pathway (ALP) | BNIP3A | Autophagy mediators | Selective elimination of damaged organelles and degradation of misfolded proteins |  | |
 |  | LC3B | Driver of skeletal muscle proteolysis |  | ||
 |  | FOXO3 | Main transcription factor that induces autophagy | Regulates the expression of autophagy genes |  | [99] |
 |  |  | Reduces IGF1/PI3K/AKT signaling pathway activity via mTOR and transcriptional dependent mechanisms | Positive regulator of ALP |  | |
 |  | ATG7 | Regulator of p38 MAPK pathway |  | [107] | |
 | Ca2 + -activated degradation | Calcium | Regulates the binding of calpastatin to calpain | Calpain activity inhibitor |  | [117] |
 |  |  | Regulation of glucocorticoid | Driver of skeletal muscle proteolysis |  | [119] |
 |  | Calpains | Cleaves myofibrillar proteins | Disrupt sarcomeres |  | |
 |  | Proteolysis-inducing factor (PIF) | Induces a high accumulation of Ca2+ | Positive regulator Ca2+-dependent degradation system |  | [122] |